volume 24 issue 4 pages 1753-1762

Modification of 3,5-bis(arylidene)-4-piperidone pharmacophore by phosphonate group using 1,2,3-triazole cycle as a linker for the synthesis of new cytostatics

Publication typeJournal Article
Publication date2014-09-20
scimago Q2
wos Q3
SJR0.470
CiteScore5.1
Impact factor3.1
ISSN10542523, 15548120
Organic Chemistry
General Pharmacology, Toxicology and Pharmaceutics
Abstract
Novel cytotoxic 3,5-bis(arylidene)-4-piperidones conjugated with phosphonate groups via 1,2,3-triazole ring have been synthesized and their antitumor properties have been evaluated. Synthetic route to these conjugates is based on 1,3-cycloaddition of diethyl (ω-azidoalkyl)phosphonates to 1-prop-2-ynyl-piperidin-4-one in the presence of Cu(I) catalyst followed by crotonic condensation of resulting 1,2,3-triazole with aromatic aldehydes. The synthesized phosphonate derivatives of 3,5-bis(arylidene)-4-piperidone series displayed high in vitro inhibitory properties toward HCT116 and MCF7 as well as CaoV3, A549, and PC3 human cancer cell lines with IC50 values in the range of 1.5–8.0 μM.
Found 
Found 

Top-30

Journals

1
Anti-Infective Agents
1 publication, 8.33%
MolBank
1 publication, 8.33%
Frontiers in Pharmacology
1 publication, 8.33%
Russian Chemical Bulletin
1 publication, 8.33%
Chemistry and Biodiversity
1 publication, 8.33%
RSC Advances
1 publication, 8.33%
Russian Journal of Organic Chemistry
1 publication, 8.33%
ChemMedChem
1 publication, 8.33%
European Journal of Medicinal Chemistry
1 publication, 8.33%
Chemistry
1 publication, 8.33%
Russian Chemical Reviews
1 publication, 8.33%
1

Publishers

1
2
MDPI
2 publications, 16.67%
Wiley
2 publications, 16.67%
Elsevier
2 publications, 16.67%
Bentham Science Publishers Ltd.
1 publication, 8.33%
Frontiers Media S.A.
1 publication, 8.33%
Springer Nature
1 publication, 8.33%
Royal Society of Chemistry (RSC)
1 publication, 8.33%
Pleiades Publishing
1 publication, 8.33%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 8.33%
1
2
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
12
Share
Cite this
GOST |
Cite this
GOST Copy
Makarov M. V. et al. Modification of 3,5-bis(arylidene)-4-piperidone pharmacophore by phosphonate group using 1,2,3-triazole cycle as a linker for the synthesis of new cytostatics // Medicinal Chemistry Research. 2014. Vol. 24. No. 4. pp. 1753-1762.
GOST all authors (up to 50) Copy
Makarov M. V., Rybalkina E. Yu., Khrustalev V. N., Röschenthaler G. Modification of 3,5-bis(arylidene)-4-piperidone pharmacophore by phosphonate group using 1,2,3-triazole cycle as a linker for the synthesis of new cytostatics // Medicinal Chemistry Research. 2014. Vol. 24. No. 4. pp. 1753-1762.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s00044-014-1262-z
UR - https://doi.org/10.1007/s00044-014-1262-z
TI - Modification of 3,5-bis(arylidene)-4-piperidone pharmacophore by phosphonate group using 1,2,3-triazole cycle as a linker for the synthesis of new cytostatics
T2 - Medicinal Chemistry Research
AU - Makarov, Mikhail V.
AU - Rybalkina, Ekaterina Yu
AU - Khrustalev, Victor N.
AU - Röschenthaler, Gerd-Volker
PY - 2014
DA - 2014/09/20
PB - Springer Nature
SP - 1753-1762
IS - 4
VL - 24
SN - 1054-2523
SN - 1554-8120
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2014_Makarov,
author = {Mikhail V. Makarov and Ekaterina Yu Rybalkina and Victor N. Khrustalev and Gerd-Volker Röschenthaler},
title = {Modification of 3,5-bis(arylidene)-4-piperidone pharmacophore by phosphonate group using 1,2,3-triazole cycle as a linker for the synthesis of new cytostatics},
journal = {Medicinal Chemistry Research},
year = {2014},
volume = {24},
publisher = {Springer Nature},
month = {sep},
url = {https://doi.org/10.1007/s00044-014-1262-z},
number = {4},
pages = {1753--1762},
doi = {10.1007/s00044-014-1262-z}
}
MLA
Cite this
MLA Copy
Makarov, Mikhail V., et al. “Modification of 3,5-bis(arylidene)-4-piperidone pharmacophore by phosphonate group using 1,2,3-triazole cycle as a linker for the synthesis of new cytostatics.” Medicinal Chemistry Research, vol. 24, no. 4, Sep. 2014, pp. 1753-1762. https://doi.org/10.1007/s00044-014-1262-z.